Candel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Candel Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Candel Therapeutics Inc
Rating: 1.73475
Author: Trendlyne DVM scores

about

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced...

8.05 0.10 (1.26%)

85.06% Gain from 52W Low

1.7M

XNAS Volume

XNAS 27 May, 2026 4:09 PM (EDT)

Board Meeting

The next board meeting for Candel Therapeutics Inc is on 03 Jun 2026 for the purpose of 2026 Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

1.5 / 100

Technically Moderately Bullish

67.9 / 100

No estimates available

Candel Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Candel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced...

85.06% Gain from 52W Low

SWOT Analysis

Candel Therapeutics Inc Live Price Chart